Cargando…

Single test-based diagnosis of multiple cancer types using Exosome-SERS-AI for early stage cancers

Early cancer detection has significant clinical value, but there remains no single method that can comprehensively identify multiple types of early-stage cancer. Here, we report the diagnostic accuracy of simultaneous detection of 6 types of early-stage cancers (lung, breast, colon, liver, pancreas,...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Hyunku, Choi, Byeong Hyeon, Shim, On, Kim, Jihee, Park, Yong, Cho, Suk Ki, Kim, Hyun Koo, Choi, Yeonho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039041/
https://www.ncbi.nlm.nih.gov/pubmed/36964142
http://dx.doi.org/10.1038/s41467-023-37403-1
_version_ 1784912196222844928
author Shin, Hyunku
Choi, Byeong Hyeon
Shim, On
Kim, Jihee
Park, Yong
Cho, Suk Ki
Kim, Hyun Koo
Choi, Yeonho
author_facet Shin, Hyunku
Choi, Byeong Hyeon
Shim, On
Kim, Jihee
Park, Yong
Cho, Suk Ki
Kim, Hyun Koo
Choi, Yeonho
author_sort Shin, Hyunku
collection PubMed
description Early cancer detection has significant clinical value, but there remains no single method that can comprehensively identify multiple types of early-stage cancer. Here, we report the diagnostic accuracy of simultaneous detection of 6 types of early-stage cancers (lung, breast, colon, liver, pancreas, and stomach) by analyzing surface-enhanced Raman spectroscopy profiles of exosomes using artificial intelligence in a retrospective study design. It includes classification models that recognize signal patterns of plasma exosomes to identify both their presence and tissues of origin. Using 520 test samples, our system identified cancer presence with an area under the curve value of 0.970. Moreover, the system classified the tumor organ type of 278 early-stage cancer patients with a mean area under the curve of 0.945. The final integrated decision model showed a sensitivity of 90.2% at a specificity of 94.4% while predicting the tumor organ of 72% of positive patients. Since our method utilizes a non-specific analysis of Raman signatures, its diagnostic scope could potentially be expanded to include other diseases.
format Online
Article
Text
id pubmed-10039041
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-100390412023-03-26 Single test-based diagnosis of multiple cancer types using Exosome-SERS-AI for early stage cancers Shin, Hyunku Choi, Byeong Hyeon Shim, On Kim, Jihee Park, Yong Cho, Suk Ki Kim, Hyun Koo Choi, Yeonho Nat Commun Article Early cancer detection has significant clinical value, but there remains no single method that can comprehensively identify multiple types of early-stage cancer. Here, we report the diagnostic accuracy of simultaneous detection of 6 types of early-stage cancers (lung, breast, colon, liver, pancreas, and stomach) by analyzing surface-enhanced Raman spectroscopy profiles of exosomes using artificial intelligence in a retrospective study design. It includes classification models that recognize signal patterns of plasma exosomes to identify both their presence and tissues of origin. Using 520 test samples, our system identified cancer presence with an area under the curve value of 0.970. Moreover, the system classified the tumor organ type of 278 early-stage cancer patients with a mean area under the curve of 0.945. The final integrated decision model showed a sensitivity of 90.2% at a specificity of 94.4% while predicting the tumor organ of 72% of positive patients. Since our method utilizes a non-specific analysis of Raman signatures, its diagnostic scope could potentially be expanded to include other diseases. Nature Publishing Group UK 2023-03-24 /pmc/articles/PMC10039041/ /pubmed/36964142 http://dx.doi.org/10.1038/s41467-023-37403-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Shin, Hyunku
Choi, Byeong Hyeon
Shim, On
Kim, Jihee
Park, Yong
Cho, Suk Ki
Kim, Hyun Koo
Choi, Yeonho
Single test-based diagnosis of multiple cancer types using Exosome-SERS-AI for early stage cancers
title Single test-based diagnosis of multiple cancer types using Exosome-SERS-AI for early stage cancers
title_full Single test-based diagnosis of multiple cancer types using Exosome-SERS-AI for early stage cancers
title_fullStr Single test-based diagnosis of multiple cancer types using Exosome-SERS-AI for early stage cancers
title_full_unstemmed Single test-based diagnosis of multiple cancer types using Exosome-SERS-AI for early stage cancers
title_short Single test-based diagnosis of multiple cancer types using Exosome-SERS-AI for early stage cancers
title_sort single test-based diagnosis of multiple cancer types using exosome-sers-ai for early stage cancers
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039041/
https://www.ncbi.nlm.nih.gov/pubmed/36964142
http://dx.doi.org/10.1038/s41467-023-37403-1
work_keys_str_mv AT shinhyunku singletestbaseddiagnosisofmultiplecancertypesusingexosomesersaiforearlystagecancers
AT choibyeonghyeon singletestbaseddiagnosisofmultiplecancertypesusingexosomesersaiforearlystagecancers
AT shimon singletestbaseddiagnosisofmultiplecancertypesusingexosomesersaiforearlystagecancers
AT kimjihee singletestbaseddiagnosisofmultiplecancertypesusingexosomesersaiforearlystagecancers
AT parkyong singletestbaseddiagnosisofmultiplecancertypesusingexosomesersaiforearlystagecancers
AT chosukki singletestbaseddiagnosisofmultiplecancertypesusingexosomesersaiforearlystagecancers
AT kimhyunkoo singletestbaseddiagnosisofmultiplecancertypesusingexosomesersaiforearlystagecancers
AT choiyeonho singletestbaseddiagnosisofmultiplecancertypesusingexosomesersaiforearlystagecancers